---
title: "Clinical Registry for the Characterization of the 'Pulmonary Vascular Phenotype' in Patients With Chronic Obstructive Pulmonary Disease"
nct_id: NCT07102823
overall_status: RECRUITING
sponsor: Medical University of Graz
study_type: OBSERVATIONAL
primary_condition: Chronic Obstructive Pulmonary Disease (COPD)
countries: Austria, Switzerland, United Kingdom
canonical_url: "https://parkinsonspathways.com/agent/trials/NCT07102823.md"
clinicaltrials_gov: "https://clinicaltrials.gov/study/NCT07102823"
ct_last_update_post_date: 2026-01-14
last_seen_at: "2026-05-12T06:11:59.785Z"
source: ClinicalTrials.gov (mirrored, no enrichment)
---
# Clinical Registry for the Characterization of the 'Pulmonary Vascular Phenotype' in Patients With Chronic Obstructive Pulmonary Disease

**Official Title:** Clinical Registry for the Characterization of the 'Pulmonary Vascular Phenotype' in Patients With Chronic Obstructive Pulmonary Disease - a Retrospective Multi-center Data Analysis

**NCT ID:** [NCT07102823](https://clinicaltrials.gov/study/NCT07102823)

## Key Facts

- **Status:** RECRUITING
- **Study Type:** OBSERVATIONAL
- **Target Enrollment:** 1000
- **Lead Sponsor:** Medical University of Graz
- **Conditions:** Chronic Obstructive Pulmonary Disease (COPD), Pulmonary Hypertension
- **Start Date:** 2025-09-01
- **Completion Date:** 2027-12-31
- **CT.gov Last Update:** 2026-01-14

## Brief Summary

Registry of COPD (Chronic Obstructive Pulmonary Disease) patients who underwent right heart catheterization (RHC) and full clinical evaluation for pulmonary hypertension

## Eligibility

- **Minimum age:** 18 Years
- **Sex:** ALL
- **Healthy Volunteers:** No

```
Inclusion Criteria:

* clinical diagnosis of COPD
* right heart catheterization including mPAP (Mean Pulmonary Artery Pressure), PVR (Pulmonary Vascular Resistance), PAWP (Pulmonary Artery Wedge Pressure), CO (cardiac output)
* age \>= 18 years

Exclusion Criteria:

* pediatric patients
* no COPD or no RHC
```

## Primary Outcomes

- **Severe Pulmonary Hypertension (PH)** _(time frame: at inclusion)_ — pulmonary vascular resistance \> 5 WU (Wood Units)
- **all-cause mortality** _(time frame: Until 2026)_ — all-cause mortality

## Locations (3)

- Medical University of Graz, Graz, Austria — _RECRUITING_
- University of Zurich, Zurich, Switzerland — _RECRUITING_
- University of Sheffield, Sheffield, United Kingdom — _RECRUITING_

## Recent Field Changes (last 30 days)

- `status.overallStatus` — added _(2026-05-12)_
- `status.primaryCompletionDate` — added _(2026-05-12)_
- `status.completionDate` — added _(2026-05-12)_
- `status.lastUpdatePostDate` — added _(2026-05-12)_
- `design.enrollmentCount` — added _(2026-05-12)_
- `eligibility.criteria` — added _(2026-05-12)_
- `eligibility.minAge` — added _(2026-05-12)_
- `eligibility.sex` — added _(2026-05-12)_
- `outcomes.primary` — added _(2026-05-12)_
- `sponsor.lead` — added _(2026-05-12)_
- `results.hasResults` — added _(2026-05-12)_
- `locations.medical university of graz|graz||austria` — added _(2026-05-12)_
- `locations.university of zurich|zurich||switzerland` — added _(2026-05-12)_
- `locations.university of sheffield|sheffield||united kingdom` — added _(2026-05-12)_

---

*Canonical: https://parkinsonspathways.com/agent/trials/NCT07102823.md*  
*Source data (authoritative): https://clinicaltrials.gov/study/NCT07102823*  
*This page is a raw mirror with no AI summary, no editorial enrichment, and no Parkinson's-specific filtering.*